The sphygmomanometer market size has grown rapidly in recent years. It will grow from $3.2 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising prevalence of hypertension, widespread use of mercury-based devices historically, increased screening in clinical settings, growth of primary healthcare facilities, adoption of manual and aneroid devices.
The sphygmomanometer market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of connected healthcare devices, expansion of telemedicine services, growing focus on preventive cardiovascular care, increasing replacement of mercury-based devices. Major trends in the forecast period include increasing adoption of digital blood pressure monitoring devices, rising demand for home-based monitoring solutions, growing integration of data connectivity features, expansion of portable and wearable configurations, enhanced focus on measurement accuracy and ease of use.
The rising burden of chronic non-communicable diseases (NCDs) is expected to drive the growth of the sphygmomanometer market in the coming years. Chronic NCDs - especially hypertension and cardiovascular disease - are long-term health conditions that develop gradually and require ongoing monitoring and management. Hypertension represents a significant global health challenge and a key risk factor for cardiovascular complications, making regular blood-pressure checks crucial for early detection and effective treatment. The increasing prevalence of these conditions is influenced by lifestyle factors such as aging populations, unhealthy diets, physical inactivity, and rising obesity rates, which collectively lead to higher incidences of blood-pressure irregularities worldwide. Sphygmomanometers enhance patient care by enabling timely diagnosis, continuous monitoring, and better management of cardiovascular risks in both clinical and home-care settings. For example, in September 2025, the World Health Organization (WHO), a Switzerland-based UN agency, reported that an estimated 1.4 billion adults aged 30-79 were affected by hypertension in 2024 - about 33 percent of this age group - with two-thirds living in low- and middle-income countries, while roughly 600 million individuals (44 percent) remained undiagnosed and approximately 630 million (44 percent) received diagnosis and treatment. Thus, the increasing burden of chronic NCDs is fueling growth in the sphygmomanometer market.
The rising number of ambulatory surgery centers is expected to further support the growth of the sphygmomanometer market. An Ambulatory Surgical Center (ASC) is a medical facility focused on performing surgical procedures that do not require overnight hospitalization. These centers heavily rely on sphygmomanometers, or blood pressure cuffs, to monitor patients’ vital signs before, during, and after surgery. For instance, in July 2025, CliftonLarsonAllen LLP, a US-based professional services firm, reported that ambulatory surgery centers are expanding in both scale and utilization, with over 10,000 facilities operating across the United States and industry revenues projected to rise from around USD 45 billion in 2024 to approximately USD 57 billion by 2030. Therefore, the growth of ambulatory surgery centers is contributing to the expansion of the sphygmomanometer market.
Leading companies in the sphygmomanometer market are focusing on developing advanced automatic blood pressure monitoring solutions that incorporate AI-driven diagnostic features to enhance measurement accuracy, enable early detection of cardiovascular abnormalities, and improve the convenience of home-based monitoring. AI-enabled automatic blood pressure monitors use machine-learning algorithms to analyze pulse-wave signals during cuff inflation, allowing them to detect irregular heart rhythms such as atrial fibrillation (AFib) while providing reliable systolic and diastolic readings. For example, in November 2024, OMRON Healthcare, a Japan-based health equipment and service provider, received FDA De Novo authorization for its next-generation home blood pressure monitor equipped with IntelliSense AFib, an AI-powered algorithm that evaluates over 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This development highlights how automatic oscillometric devices are evolving from basic blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.
Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc.
North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sphygmomanometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the sphygmomanometer market by increasing costs of imported electronic sensors, pressure gauges, microcontrollers, and display components used in digital and automated devices. Healthcare facilities in North America and Europe are most affected due to reliance on imported electronic parts, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising device prices and slowing replacement cycles. However, they are also encouraging local assembly, regional electronics sourcing, and domestic production of digital blood pressure monitors.
The sphygmomanometer market research report is one of a series of new reports that provides sphygmomanometer market statistics, including sphygmomanometer industry global market size, regional shares, competitors with a sphygmomanometer market share, detailed sphygmomanometer market segments, market trends and opportunities, and any further data you may need to thrive in the sphygmomanometer industry. This sphygmomanometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A sphygmomanometer is a device designed for measuring blood pressure, specifically the pressure in arteries. It comprises an inflatable cuff, which is used to restrict blood flow, and a gauge to measure the pressure.
The primary types of sphygmomanometers include electronic sphygmomanometers, aneroid sphygmomanometers, and mercury sphygmomanometers. An electronic sphygmomanometer is a medical device utilized for measuring blood pressure. It finds applications in clinical settings and is also suitable for self-monitoring of blood pressure at home. These electronic sphygmomanometers come in various configurations, including portable, desk-mounted, floor-standing, and wall-mounted options. They operate using electricity and may be manual, automatic, or semi-automatic. These devices are commonly employed in diverse healthcare settings such as hospitals, ambulatory surgical centers, clinics, home healthcare, and other end-user environments.
The sphygmomanometer market consists of the sale of digital sphygmomanometers, portable sphygmomanometers, and hybrid sphygmomanometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The sphygmomanometer market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of connected healthcare devices, expansion of telemedicine services, growing focus on preventive cardiovascular care, increasing replacement of mercury-based devices. Major trends in the forecast period include increasing adoption of digital blood pressure monitoring devices, rising demand for home-based monitoring solutions, growing integration of data connectivity features, expansion of portable and wearable configurations, enhanced focus on measurement accuracy and ease of use.
The rising burden of chronic non-communicable diseases (NCDs) is expected to drive the growth of the sphygmomanometer market in the coming years. Chronic NCDs - especially hypertension and cardiovascular disease - are long-term health conditions that develop gradually and require ongoing monitoring and management. Hypertension represents a significant global health challenge and a key risk factor for cardiovascular complications, making regular blood-pressure checks crucial for early detection and effective treatment. The increasing prevalence of these conditions is influenced by lifestyle factors such as aging populations, unhealthy diets, physical inactivity, and rising obesity rates, which collectively lead to higher incidences of blood-pressure irregularities worldwide. Sphygmomanometers enhance patient care by enabling timely diagnosis, continuous monitoring, and better management of cardiovascular risks in both clinical and home-care settings. For example, in September 2025, the World Health Organization (WHO), a Switzerland-based UN agency, reported that an estimated 1.4 billion adults aged 30-79 were affected by hypertension in 2024 - about 33 percent of this age group - with two-thirds living in low- and middle-income countries, while roughly 600 million individuals (44 percent) remained undiagnosed and approximately 630 million (44 percent) received diagnosis and treatment. Thus, the increasing burden of chronic NCDs is fueling growth in the sphygmomanometer market.
The rising number of ambulatory surgery centers is expected to further support the growth of the sphygmomanometer market. An Ambulatory Surgical Center (ASC) is a medical facility focused on performing surgical procedures that do not require overnight hospitalization. These centers heavily rely on sphygmomanometers, or blood pressure cuffs, to monitor patients’ vital signs before, during, and after surgery. For instance, in July 2025, CliftonLarsonAllen LLP, a US-based professional services firm, reported that ambulatory surgery centers are expanding in both scale and utilization, with over 10,000 facilities operating across the United States and industry revenues projected to rise from around USD 45 billion in 2024 to approximately USD 57 billion by 2030. Therefore, the growth of ambulatory surgery centers is contributing to the expansion of the sphygmomanometer market.
Leading companies in the sphygmomanometer market are focusing on developing advanced automatic blood pressure monitoring solutions that incorporate AI-driven diagnostic features to enhance measurement accuracy, enable early detection of cardiovascular abnormalities, and improve the convenience of home-based monitoring. AI-enabled automatic blood pressure monitors use machine-learning algorithms to analyze pulse-wave signals during cuff inflation, allowing them to detect irregular heart rhythms such as atrial fibrillation (AFib) while providing reliable systolic and diastolic readings. For example, in November 2024, OMRON Healthcare, a Japan-based health equipment and service provider, received FDA De Novo authorization for its next-generation home blood pressure monitor equipped with IntelliSense AFib, an AI-powered algorithm that evaluates over 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This development highlights how automatic oscillometric devices are evolving from basic blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.
Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc.
North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sphygmomanometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the sphygmomanometer market by increasing costs of imported electronic sensors, pressure gauges, microcontrollers, and display components used in digital and automated devices. Healthcare facilities in North America and Europe are most affected due to reliance on imported electronic parts, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising device prices and slowing replacement cycles. However, they are also encouraging local assembly, regional electronics sourcing, and domestic production of digital blood pressure monitors.
The sphygmomanometer market research report is one of a series of new reports that provides sphygmomanometer market statistics, including sphygmomanometer industry global market size, regional shares, competitors with a sphygmomanometer market share, detailed sphygmomanometer market segments, market trends and opportunities, and any further data you may need to thrive in the sphygmomanometer industry. This sphygmomanometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A sphygmomanometer is a device designed for measuring blood pressure, specifically the pressure in arteries. It comprises an inflatable cuff, which is used to restrict blood flow, and a gauge to measure the pressure.
The primary types of sphygmomanometers include electronic sphygmomanometers, aneroid sphygmomanometers, and mercury sphygmomanometers. An electronic sphygmomanometer is a medical device utilized for measuring blood pressure. It finds applications in clinical settings and is also suitable for self-monitoring of blood pressure at home. These electronic sphygmomanometers come in various configurations, including portable, desk-mounted, floor-standing, and wall-mounted options. They operate using electricity and may be manual, automatic, or semi-automatic. These devices are commonly employed in diverse healthcare settings such as hospitals, ambulatory surgical centers, clinics, home healthcare, and other end-user environments.
The sphygmomanometer market consists of the sale of digital sphygmomanometers, portable sphygmomanometers, and hybrid sphygmomanometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Sphygmomanometer Market Characteristics
3. Sphygmomanometer Market Supply Chain Analysis
4. Global Sphygmomanometer Market Trends and Strategies
5. Sphygmomanometer Market Analysis of End Use Industries
7. Global Sphygmomanometer Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Sphygmomanometer Total Addressable Market (TAM) Analysis for the Market
9. Sphygmomanometer Market Segmentation
10. Sphygmomanometer Market Regional and Country Analysis
11. Asia-Pacific Sphygmomanometer Market
12. China Sphygmomanometer Market
13. India Sphygmomanometer Market
14. Japan Sphygmomanometer Market
15. Australia Sphygmomanometer Market
16. Indonesia Sphygmomanometer Market
17. South Korea Sphygmomanometer Market
18. Taiwan Sphygmomanometer Market
19. South East Asia Sphygmomanometer Market
20. Western Europe Sphygmomanometer Market
21. UK Sphygmomanometer Market
22. Germany Sphygmomanometer Market
23. France Sphygmomanometer Market
24. Italy Sphygmomanometer Market
25. Spain Sphygmomanometer Market
26. Eastern Europe Sphygmomanometer Market
27. Russia Sphygmomanometer Market
28. North America Sphygmomanometer Market
29. USA Sphygmomanometer Market
30. Canada Sphygmomanometer Market
31. South America Sphygmomanometer Market
32. Brazil Sphygmomanometer Market
33. Middle East Sphygmomanometer Market
34. Africa Sphygmomanometer Market
36. Sphygmomanometer Market Competitive Landscape and Company Profiles
37. Sphygmomanometer Market Other Major and Innovative Companies
40. Sphygmomanometer Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Sphygmomanometer Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses sphygmomanometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sphygmomanometer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sphygmomanometer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Electronic Sphygmomanometer; Aneroid Sphygmomanometer; Mercury Sphygmomanometer2) By Configuration: Portable; Desk Mounted; Floor Standing; Wall Mounted
3) By Operation: Electric; Manual; Automatic; Semi-automatic
4) By End User: Hospitals; Ambulatory Surgical Centers And Clinics; Home Healthcare; Other End Users
Subsegments:
1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer; Wrist Electronic Sphygmomanometer; Finger Electronic Sphygmomanometer2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer; Digital Aneroid Sphygmomanometer
3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer; Portable Mercury Sphygmomanometer
Companies Mentioned: A&D Company Ltd.; American Diagnostic Corporation; Omron Healthcare Inc.; Microlife Corporation; Beurer GmbH; CIGA Healthcare Ltd.; Rossmax International Ltd.; Rudolf Riester GmbH; Welch Allyn Inc.; Koninklijke Philips N.V.; Paul Hartmann AG; Spengler; Holtex Ltd.; Timesco Healthcare Ltd.; Bremed Ltd.; iHealth Labs Inc.; Contec Medical Systems Co. Ltd.; SunTech Medical Inc.; General Electric Company; Amico Group of Companies; HEINE Optotechnik GmbH and Co. KG; Hill-Rom Services Inc.; Halma plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Sphygmomanometer market report include:- A&D Company Ltd.
- American Diagnostic Corporation
- Omron Healthcare Inc.
- Microlife Corporation
- Beurer GmbH
- CIGA Healthcare Ltd.
- Rossmax International Ltd.
- Rudolf Riester GmbH
- Welch Allyn Inc.
- Koninklijke Philips N.V.
- Paul Hartmann AG
- Spengler
- Holtex Ltd.
- Timesco Healthcare Ltd.
- Bremed Ltd.
- iHealth Labs Inc.
- Contec Medical Systems Co. Ltd.
- SunTech Medical Inc.
- General Electric Company
- Amico Group of Companies
- HEINE Optotechnik GmbH and Co. KG
- Hill-Rom Services Inc.
- Halma plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.53 Billion |
| Forecasted Market Value ( USD | $ 5.31 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
